EMALT 10 mg raspadljive tablete za usta Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

emalt 10 mg raspadljive tablete za usta

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - rizatriptanbenzoat - raspadljiva tableta za usta - 10 mg - urbroj: jedna raspadljiva tableta za usta sadrži 10 mg rizatriptana (u obliku rizatriptanbenzoata)

Penon 50 mg/ml prašak za oralnu suspenziju Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

penon 50 mg/ml prašak za oralnu suspenziju

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - fenoksimetilpenicilinkalij - prašak za oralnu suspenziju - urbroj: jedan mlilitar pipremljene suspenzije sadrži 50 mg fenoksimetilpenicilinkalija

Suiseng Diff/A Europska Unija - hrvatski - EMA (European Medicines Agency)

suiseng diff/a

laboratorios hipra, s.a. - clostridioides difficile toxoid a, clostridioides difficile toxoid b, clostridium perfringens, type a, alpha toxoid - immunologicals for suidae, inactivated bacterial vaccines for pigs, clostridium - svinje - for the passive immunisation of neonatal piglets by means of the active immunisation of breeding sows and gilts:- to prevent mortality and reduce clinical signs and macroscopic lesions caused by clostridioides difficile toxins a and b. - to reduce clinical signs and macroscopic lesions caused by clostridium perfringens type a, alpha toxin.

Ximon 60 mg obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

ximon 60 mg obložene tablete

alpha-medical d.o.o., dragutina golika 36, zagreb, hrvatska - piridostigminijev bromid - obložena tableta - urbroj: jedna obložena tableta sadrži 60 mg piridostigminijeva bromida

Alphalben 100 mg/mL Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

alphalben 100 mg/ml

alpha-vet animal health ltd., hoffner albert str. 38-40, 1194 budimpešta, mađarska - albendazol - oralna suspenzija - albendazol - goveda, ovaca

Alphaflorosol 100 mg/mL otopina za primjenu u vodi za piće za kokoši i svinje Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

alphaflorosol 100 mg/ml otopina za primjenu u vodi za piće za kokoši i svinje

alpha-vet animal health ltd., h-1194 budimpešta, hofherr a. u. 42., mađarska - florfenikol - otopina za primjenu u vodi za piće - florfenikol - kokoši (tovni pilići), svinja

Alpha Trancell Deluxe MR Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

alpha trancell deluxe mr

mediva d.o.o. savska cesta 141 10000 zagreb -

ALPHA DIP Vib Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

alpha dip vib

pharmaq as, skogmo industriområde, industrivegen 50, 7863 overhalla, norveška - inaktivirana listonella anguillarum (vibrio anguillarum), serotip o1, soj al 112 - koncentrat za suspenziju za kupku - lubina (dicentrarchus labrax l)

ALPHA JECT micro 2000 Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

alpha ject micro 2000

pharmaq as, skogmo industriområde, industrivegen 50, 7863 overhalla, norveška - inaktivirana vibrio (listonella) anguillarum, serotip o1, soj al 112; inaktivirana photobacterium damselae subsp. piscicida, soj al 5051 - emulzija za injekciju - brancina (dicentrarchus labrax)

Imatinib Accord Europska Unija - hrvatski - EMA (European Medicines Agency)

imatinib accord

accord healthcare s.l.u. - imatinib - precursor cell lymphoblastic leukemia-lymphoma; dermatofibrosarcoma; myelodysplastic-myeloproliferative diseases; leukemia, myelogenous, chronic, bcr-abl positive; hypereosinophilic syndrome - imatinib - imatinib accord is indicated for the treatment of- adult and paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment. - adult and paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis. - adult and paediatric patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy. - adult patients with relapsed or refractory ph+ all as monotherapy. - adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements. - adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfrα rearrangement. - adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. - the treatment of adult patients with kit (cd 117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). - the adjuvant treatment of adult patients who are at significant risk of relapse following resection of kit (cd117)-positive gist. patients who have a low or very low risk of recurrence should not receive adjuvant treatmentthe effect of imatinib on the outcome of bone marrow transplantation has not been determined. in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. the experience with imatinib in patients with mds/mpd associated with pdgfr gene re-arrangements is very limited (see section 5. osim po prvi put prijavljene kronične fazi kml, nema kontroliranih istraživanja pokazuju klinički učinak ili povećava stopu preživljavanja kod te bolesti. .